Foley Catheterization Following Sacrocolpopexy
The objective of this study is to prospectively evaluate the effects of early versus delayed removal of transuretheral catheters following sacrocolpopexy. The investigators specific aim is to determine the optimal time of removal of an indwelling transurethral catheter postoperatively in an effort to reduce the risk of postoperative urinary retention and urinary tract infection associated with catheter use. The investigators hypotheses are as follows:
Hypothesis 1: Longer duration of postoperative catheter use will result in decreased postoperative urinary retention.
Hypothesis 2: Shorter duration of postoperative catheter use will result in lower incidence of urinary tract infection.
Pelvic Organ Prolapse
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Urinary Bladder Catheterization Following Sacrocolpopexy|
- Urinary retention following catheter removal [ Time Frame: 2 days ] [ Designated as safety issue: No ]
- need for repeat catheterization [ Time Frame: 2 days ] [ Designated as safety issue: No ]
- Presence of bacteriuria at catheter removal [ Time Frame: 2 days ] [ Designated as safety issue: No ]
|Study Start Date:||August 2011|
|Study Completion Date:||April 2013|
|Primary Completion Date:||April 2013 (Final data collection date for primary outcome measure)|
1 day catheter removal
Participants randomized to group 1 will have their catheter removed 1 day after surgery.
2 day catheter removal
Participants randomized to group 2 will have their catheter removed 2 days after surgery.
Patients scheduled to undergo sacrocolpopexy for pelvic organ prolapse at the University of Oklahoma Health Sciences Center will be recruited for this study. Written informed consent will be obtained from all participants prior to the scheduled surgery and before the randomization process. This study will contain two arms, each with two groups. The first arm will have participants receiving sacrocolpopexy for pelvic organ prolapse; the second arm will consist of participants receiving sacrocolpopexy plus a concomitant procedure for stress urinary incontinence. Each participant will be assigned to the arm that matches their scheduled procedure; they will then be randomized into one of the two study groups within that arm. Randomization will be performed by placing note cards in sealed envelopes with "Group A" or "Group B" listed on the card. One envelope will be placed with each participant's preoperative packet and opened on the day of surgery after the operation is complete.On the date of the procedure, a urinalysis will be performed prior to the routine administration of prophylactic antibiotics. At the beginning of the procedure, a transurethral catheter will be placed as is routine for this procedure. At the conclusion of the procedure, the sealed envelope containing the participant's group designation will be opened and she will be assigned to one of two groups. Group A participants will have their catheter removed on postoperative day 1 and Group B will have their catheter removed on postoperative day 2.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01525498
|United States, Oklahoma|
|University of Oklahoma Health Sciences Center|
|Oklahoma City, Oklahoma, United States, 73104|
|Principal Investigator:||Abbas Shobeiri, MD||University of Oklahoma|